Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Somero revenue short of outlook; SigmaRoc optimistic

Fri, 03rd Feb 2023 13:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Somero Enterprises Inc - Fort Myers, Florida-based laser-guided machinery concrete levelling specialist - Expects 2022 revenue of USD134.0 million, surpassing 2021's USD133.3 million. However, revenue is down from USD138.8 million guidance. This is due to "supply chain shortages in our North America market on our customers' pace of work". "The board is pleased with the strong finish to 2022 and looks forward to 2023 with confidence based on the strength of the US market, direct feedback from our customer base on activity, and the growth opportunity in Europe and Australia and from new products. To capture this opportunity, the company remains committed to adding product development, sales, and support resources; a necessary near-term investment and cost with longer-term benefit," Somero says.

----------

SigmaRoc PLC - London-based quarried materials company - Says revenue grows 19% on organic like-for-like basis to GBP525 million in 2022. On reported basis, revenue improves 93% from GBP272.0 million. Expects underlying earnings before interest, tax, depreciation and amortisation to top GBP100 million, more than doubling from GBP49.3 million. Company adds: "Trading in the early weeks of FY23 has been encouraging, with more favourable energy cost and availability conditions supporting better than expected demand in a number of the group's European industrial products segments. The group has continued to take a dynamic position on pricing through inflationary cost increases, as well as identifying opportunities to improve efficiency across its network. As such, the board remains confident in the group's ability to achieve further progress in 2023."

----------

Mycelx Technologies Corp - clean water and clean air technology company - Beats guidance as achieves 2022 revenue of USD10.0 million, up from USD8.5 million in 2021. "Mycelx has made an encouraging start to 2023, having secured a purchase order for a six-month paid trial for a PFAS remediation system for treatment of landfill leachate, a potentially large market segment for the company's PFAS remediation offering. Subject to current market conditions continuing, the company expects to meet current guidance for 2023," company adds. PFAS is a waste water removal system.

----------

Ricardo PLC - West Sussex, England-based environmental and engineering consulting - Says trading in six months to December 31 in line with board expectations. Hails "good revenue and underlying profit growth". Annual outlook unchanged. Says order intake during six-month period was 425 higher on-year at GBP290 million.

----------

accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - Expects 2022 revenue of "not less" than USD139 million, beating initial forecast. Revenue in 2021 amounted to USD134.8 million, so company expects rise of around 11%. "The group's expected full year performance underscores the increased demand for its range of innovative and highly differentiated technology, along with continued commitment to revenue growth and operational excellence," company says.

----------

TPXimpact Holdings PLC - London-based IT consulting firm - Expects third-quarter revenue to fall 3.95 to GBP19.0 million from GBP19.8 million. Gross profit weakens 15% to GBP5.2 million from GBP6.1 million. Lowers annual guidance, now expects revenue of GBP80 million, down from previous outlook of GBP90 million.

----------

Vector Capital PLC - London-based commercial lending group - Expects 2022 revenue of GBP5.9 million, in line with market expectations and up 12% from GBP5.3 million in 2021. Loan book grows 15% to GBP53.4 million at year-end, from GBP46.3 million. "Despite current market conditions, the group is able in most cases to pass on interest rate increases and continues to witness strong demand from potential customers introduced by its established broker network. The company is benefitting from its diverse portfolio as it increases it weighting towards lower value loans, reflected in the average year-end loan figures referred to above," Vector Capital says.

----------

Microlise Group PLC - Nottingham, England-based transport management software firm - Adjusted earnings before interest, tax, depreciation, and amortisation "slightly ahead of market expectations" in 2022. Expects revenue growth of 5% to GBP63.2 million. However, notes "industry headwinds" and supply chain disruption. "This resulted in non-recurring revenues slightly below our forecasts. However, the company delivered record levels of OEM sales which impacted sales mix and had positive working capital effect," Microlise adds.

----------

Venture Life Group PLC - Berkshire, England-based self-care product manufacturer and distributor - Expects to post 2022 revenue of GBP44.0 million, up 34% from GBP32.8 million in 2021. Outcome would be "slightly ahead of market expectations". Adjusted earnings before interest, tax, depreciation, and amortisation to be at least in line with market expectations.

----------

Cambridge Cognition Holdings PLC - Cambridge, England-based digital health products technology developer - Says revenue for 2022 ahead of market expectations, rising 25% to GBP12.6 million from GBP10.1 million. "Order intake for the year closed at GBP13.1 million, up 8% on the previous year's order intake of GBP12.1 million, excluding GBP3.6 million of large one-off orders taken in 2021. Order growth continued across the expanded product offering, driven in part by the continued demand for virtual clinical trials," company adds.

----------

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Signs lease for laboratory space at MediCity in Nottingham. Also names Cathy Tralau-Stewart as chief scientific officer on permanent basis. Had been installed in post on interim basis. "She will also actively support the company strategically through membership of the executive team and as a board observer," ValiRx says.

----------

Goodbody Health Ltd - Somerset, England-based wellness company focusing on local community measures - Makes progress in phlebotomy services offering. Phlebotomy refers to using a needle to take blood from a vein. "The company has signed 4 phlebotomy contracts with other testing suppliers who wish to use Goodbody Clinics as a phlebotomy partner," Goodbody says.

----------

Northcoders Group PLC - Manchester-based software coding training provider - Says financial results for 2022 in line with expectations. Northcoders adds that revenue visibility for 2023 stands at GBP5.4 million an increase of 79% from this time last year. Company adds: "With demand continuing to achieve record highs, the board is confident about the group's prospects of the forthcoming year. The strong performance of the group has given the board confidence to invest additional funds to support the growth this year and beyond, and it intends to launch new growth initiatives to broaden the opportunities and appeal of the group's courses."

----------

Lift Global Ventures PLC - Financial media and energy sector focused investor - Subscribes for USD750,000 of unsecured convertible loan notes in Trans-Africa Energy Ltd. New investee is focused on developing of energy infrastructure projects located in Sub-Saharan Africa.

----------

Resolute Mining Ltd - Africa-focused gold miner - Quarterly gold output in final quarter of 2022 amounts to 91,777 ounces, from 79,816 ounces a year earlier. For 2022, output amounts to 353,069 ounces, beating 345,000 ounces guidance. For 2023, expects output of 350,000 ounces.

----------

Kendrick Resources PLC - exploration company focused on Norway, Sweden and Finland - Begins maiden diamond drill programme as Espedalen nickel project in Norway. In addition, names Martyn Churchouse as managing director. "Drilling will focus on the Stormyra ore body," Kendrick says.

----------

Clean Power Hydrogen PLC - Doncaster, England-based green hydrogen technology and manufacturing company - Strikes manufacturing agreement with New Zealand-based Fabrum Solutions Ltd. Fabrum is a cryogenic systems manufacturers for gas separation and hydrogen liquefaction. Fabrum will have right to manufacture MFE220 units in New Zealand on non-exclusive basis. "In addition, [Clean Power Hydrogen] has granted Fabrum a non-exclusive license to sell [Clean Power Hydrogen] products in New Zealand and Australia whereby [Clean Power Hydrogen] will receive a technology fee per unit," Clean Power says.

----------

Ecora Resources PLC - London-based natural resources royalty company - Hails "record" portfolio contribution of USD143.1 million in 2022, up 67% from USD85.6 million in 2021 as benefits from higher commodity prices. In fourth quarter alone, portfolio contribution falls 48% to USD17.8 million from USD34.1 million in the third quarter.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Oct 2019 15:22

Cambridge Cognition hoping to ride coat-tails of Biogen Alzheimer's programme

(Sharecast News) - Cambridge Cognition announced on Friday that, Following a consultation with the US Food and Drug Administration (FDA), Biogen and Eisai have announced plans to pursue regulatory approval for 'aducanumab', which would be the first therapy to tackle clinical decline in early Alzheimer's disease.

Read more
25 Oct 2019 10:37

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Read more
26 Sep 2019 16:33

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

Read more
23 Sep 2019 17:13

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

Read more
19 Sep 2019 11:52

Cambridge Cognition Interim Revenue Falls As Clinical Trial Sales Lag

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC on Thursday reported a fall in interim revenue in line with previous guidance that sales were lower than the six

Read more
12 Sep 2019 16:21

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 13 September  JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment

Read more
27 Aug 2019 10:28

WINNERS & LOSERS SUMMARY: Carpetright Up After Shareholder Helps Out

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - LOSERS----------Ferguson,

Read more
27 Aug 2019 09:35

Cambridge Cognition Shares Plunge 40% On Increased Loss Guidance

(Alliance News) - Shares in Cambridge Cognition Holdings PLC collapsed Tuesday after the company said it expects to report its loss widened in the first half due to "difficult" trading a

Read more
27 Aug 2019 09:17

Cambridge Cognition shares tumble after profit warning

(Sharecast News) - Digital solutions developer Cambridge Cognition warned on Tuesday that interim losses looked set to widen after revenues dwindled and costs grew in the six months ended 30 June.

Read more
19 Jul 2019 10:37

Cambridge Cognition Inks NeuroVocalix Deal With Pharma Firm

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC said it has secured a second commercial partnership with an undisclosed pharmaceutical company for its in the at

Read more
1 Jul 2019 15:48

Cambridge Cognition Names Vertual Boss Debra Leeves As Non-Executive

(Alliance News) - Cambridge Cognition Holdings PLC on Monday said it appointed Debra Leeves as a non-executive director with immediate effect.The neuroscience technology company said Leeves

Read more
25 Apr 2019 14:13

Cambridge Cognition To Shuffle Leadership Team At AGM

LONDON (Alliance News) - Neuroscience firm Cambridge Cognition Holdings PLC on Thursday announced a change of leadership at its upcoming annual general meeting.Cambridge Cognition's be

Read more
19 Mar 2019 11:20

Cambridge Cognition wins biggest digital health contract to date

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced a "significant" new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.

Read more
14 Mar 2019 14:03

Lombard Odier Asset Management Holds 5.8% Cambridge Cognition Stake (ALLISS)

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that Lombard Odier Asset Management Europe Ltd holds a 5.75% stake in the cognitive assessment software firm after a on the

Read more
7 Mar 2019 12:32

Cambridge Cognition slips as low order intake sends loss deeper

(Sharecast News) - Cambridge Cognition's shares slipped on Thursday after it reported that low order intake from 2017 had caused its annual losses to widen and revenues to fall.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.